Peak Bone Mass in Young HIV-Infected Patients Compared With Healthy Controls

Eugènia Negredo(Universitat de Vic - Universitat Central de Catalunya), Bonaventura Clotet(Universitat de Vic - Universitat Central de Catalunya), Antonio José Navarro(Bellvitge University Hospital), Adrián Curran(Lexington City Schools), Valentina Isernia(Hospital Clínico San Carlos), Jordi Puig(Universitat Autònoma de Barcelona), Peré Domingo(Hospital de Sant Pau), Anna Bonjoch(Universitat Autònoma de Barcelona), Núria Pérez‐Álvarez(Universitat Autònoma de Barcelona), Daniel Podzamczer(Bellvitge University Hospital), Joaquim Rosales(MedSIR (Spain)), Elena Ferrer(Hospital Universitari Germans Trias i Pujol), Patricia Echeverría(Universitat Autònoma de Barcelona), Vicente Estrada(Instituto de Salud Carlos III)
JAIDS Journal of Acquired Immune Deficiency Syndromes
October 3, 2013
10.1097/01.qai.0000435598.20104.d6
Cited by 35

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
|The Lancet|2006|343